Reevaluation of the Role of Extracellular Signal-Regulated Kinase 3 in Perinatal Survival and Postnatal Growth Using New Genetically Engineered Mouse Models
Overview
Authors
Affiliations
The physiological functions of the atypical mitogen-activated protein kinase extracellular signal-regulated kinase 3 (ERK3) remain poorly characterized. Previous analysis of mice with a targeted insertion of the reporter in the locus ( ) showed that inactivation of ERK3 in mice leads to perinatal lethality associated with intrauterine growth restriction, defective lung maturation, and neuromuscular anomalies. To further explore the role of ERK3 in physiology and disease, we generated novel mouse models expressing a catalytically inactive ( ) or conditional ( ) allele of ERK3. Surprisingly, we found that mice devoid of ERK3 kinase activity or expression survive the perinatal period without any observable lung or neuromuscular phenotype. ERK3 mutant mice reached adulthood, were fertile, and showed no apparent health problem. However, analysis of growth curves revealed that ERK3 kinase activity is necessary for optimal postnatal growth. To gain insight into the genetic basis underlying the discrepancy in phenotypes of different mutant mouse models, we analyzed the regulation of genes flanking the locus by quantitative PCR. We found that the expression of several neighboring genes is deregulated in mice but not in or mutant mice. Our genetic analysis suggests that off-target effects of the targeting construct on local gene expression are responsible for the perinatal lethality phenotype of mutant mice.
Role of the Atypical MAPK ERK3 in Cancer Growth and Progression.
Elkhadragy L, Myers A, Long W Cancers (Basel). 2024; 16(7).
PMID: 38611058 PMC: 11011113. DOI: 10.3390/cancers16071381.
One-step generation of a conditional allele in mice using a short artificial intron.
Cassidy A, Thomas D, Kuliyev E, Chen H, Pelletier S Heliyon. 2023; 8(12):e12630.
PMID: 36619446 PMC: 9816766. DOI: 10.1016/j.heliyon.2022.e12630.
On the Therapeutic Potential of ERK4 in Triple-Negative Breast Cancer.
Boudghene-Stambouli F, Soulez M, Ronkina N, Dorrie A, Kotlyarov A, Seternes O Cancers (Basel). 2023; 15(1).
PMID: 36612022 PMC: 9817496. DOI: 10.3390/cancers15010025.
Novel methods for the generation of genetically engineered animal models.
Cassidy A, Onal M, Pelletier S Bone. 2022; 167:116612.
PMID: 36379415 PMC: 9936561. DOI: 10.1016/j.bone.2022.116612.
FBXW7-mediated ERK3 degradation regulates the proliferation of lung cancer cells.
An H, Lee C, Lee G, Choi Y, Jeung D, Chen W Exp Mol Med. 2022; 54(1):35-46.
PMID: 35022544 PMC: 8813941. DOI: 10.1038/s12276-021-00721-9.